ATE460179T1
(de)
*
|
1995-04-14 |
2010-03-15 |
Us Gov Health & Human Serv |
Verfahren zur herbeiführung einer immuntoleranz mit hilfe von immuntoxinen
|
US7288254B2
(en)
|
1995-10-30 |
2007-10-30 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services, Nih |
Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
|
US7696338B2
(en)
|
1995-10-30 |
2010-04-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Immunotoxin fusion proteins and means for expression thereof
|
US7517527B2
(en)
|
1995-10-30 |
2009-04-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Immunotoxin with in vivo T cell suppressant activity and methods of use
|
US7125553B1
(en)
|
1996-04-15 |
2006-10-24 |
The United States of America as represented by the Department of Health and Human Services c/o Centers for Disease Control and Prevention |
Methods of inducing immune tolerance using immunotoxins
|
WO1998039425A2
(en)
*
|
1997-03-05 |
1998-09-11 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Vectors and methods for expression of mutant proteins
|
ATE433998T1
(de)
|
1997-03-05 |
2009-07-15 |
Us Health |
Divalent anti-t-zellen immuntoxinen und deren verwendung
|
US6676943B1
(en)
|
1997-04-24 |
2004-01-13 |
Regents Of The University Of Minnesota |
Human complement C3-degrading protein from Streptococcus pneumoniae
|
CN1086945C
(zh)
*
|
1997-06-03 |
2002-07-03 |
胡章英 |
白喉口服液
|
GB9923060D0
(en)
*
|
1999-09-29 |
1999-12-01 |
Chiron Spa |
Vaccine
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
GB0211118D0
(en)
*
|
2002-05-15 |
2002-06-26 |
Polonelli Luciano |
Vaccines
|
WO2004011027A1
(en)
*
|
2002-07-30 |
2004-02-05 |
Baxter International Inc. |
Chimeric multivalent polysaccharide conjugate vaccines
|
US7785608B2
(en)
*
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
US7301554B2
(en)
*
|
2002-09-20 |
2007-11-27 |
Ricoh Company, Ltd. |
Light scanning device, scanning line adjusting method, scanning line adjusting control method, image forming apparatus, and image forming method
|
DK2336147T3
(da)
|
2003-12-17 |
2014-06-10 |
Wyeth Llc |
Beta-immunogen-peptid-bærerkonjugater og fremgangsmåder til fremstilling deraf
|
PT1701968E
(pt)
|
2003-12-17 |
2015-09-11 |
Wyeth Llc |
Conjugados de transportadores de péptidos imunogénicos e métodos para produzir os mesmos
|
GB0505996D0
(en)
|
2005-03-23 |
2005-04-27 |
Glaxosmithkline Biolog Sa |
Fermentation process
|
US7709001B2
(en)
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
EP2425854A1
(en)
|
2005-04-08 |
2012-03-07 |
Wyeth LLC |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
US8808707B1
(en)
|
2006-05-08 |
2014-08-19 |
Wyeth Llc |
Pneumococcal dosing regimen
|
US9107880B2
(en)
|
2006-05-31 |
2015-08-18 |
Silvio Buzzi |
Pharmaceutical use of protein molecules immunologically correlated to diptheria toxin
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
CN101265288B
(zh)
*
|
2007-03-13 |
2012-03-21 |
齐鲁制药有限公司 |
Crm197突变体的纯化方法
|
DK2424562T3
(en)
|
2009-04-30 |
2015-12-07 |
Coley Pharm Group Inc |
Pneumococcal vaccine and uses thereof
|
ES2959890T3
(es)
|
2009-06-22 |
2024-02-28 |
Wyeth Llc |
Composiciones y procedimientos para preparar composiciones inmunogénicas de conjugado de polisacárido capsular de serotipo 8 de Staphylococcus aureus
|
MX2012000044A
(es)
|
2009-06-22 |
2012-01-30 |
Wyeth Llc |
Composiciones inmunogenicas de antigenos de staphylococcus aureus.
|
IT1398927B1
(it)
|
2009-06-25 |
2013-03-28 |
Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase Csgi |
Espressione batterica di un gene artificiale per la produzione di crm197 e derivati.
|
AU2010201410B2
(en)
*
|
2010-03-30 |
2015-04-30 |
Pelican Technology Holdings, Inc. |
High level expression of recombinant CRM197
|
AU2011238711B2
(en)
|
2010-03-30 |
2015-06-18 |
Pelican Technology Holdings, Inc. |
High level expression of recombinant toxin proteins
|
DK2575870T3
(en)
|
2010-06-04 |
2017-02-13 |
Wyeth Llc |
vaccine Formulations
|
WO2011154878A1
(en)
|
2010-06-07 |
2011-12-15 |
Pfizer Vaccines Llc |
Ige ch3 peptide vaccine
|
EP2608805B1
(en)
|
2010-08-23 |
2017-07-05 |
Wyeth LLC |
STABLE FORMULATIONS OF NEISSERIA MENINGITIDIS rLP2086 ANTIGENS
|
JP5976652B2
(ja)
|
2010-09-10 |
2016-08-24 |
ワイス・エルエルシー |
髄膜炎菌orf2086抗原の非脂質化変異体
|
MX346245B
(es)
|
2011-06-01 |
2017-03-13 |
Univ Xiamen |
Proteina de fusion que comprende el mutante crm197 no toxico de toxina de difteria.
|
CA2960030C
(en)
|
2012-03-09 |
2020-02-25 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
US9169304B2
(en)
|
2012-05-01 |
2015-10-27 |
Pfenex Inc. |
Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
|
KR102057217B1
(ko)
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
US9777076B2
(en)
|
2012-07-16 |
2017-10-03 |
Pfizer Inc. |
Saccharides and uses thereof
|
CN102766647A
(zh)
*
|
2012-07-25 |
2012-11-07 |
天津康希诺生物技术有限公司 |
在白喉杆菌中稳定复制的表达载体及含该载体的白喉杆菌
|
EP3421051B1
(en)
|
2012-08-16 |
2020-05-13 |
Pfizer Inc |
Glycoconjugation processes and compositions
|
CA2896552A1
(en)
|
2012-10-03 |
2014-04-10 |
Novartis Ag |
Immunogenic compositions
|
KR20140075201A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
SI2935299T1
(sl)
|
2012-12-20 |
2019-12-31 |
Pfizer Inc. |
Postopek glikokonjugacije
|
JP6359561B2
(ja)
|
2013-01-04 |
2018-07-18 |
オービーアイ ファーマ インコーポレイテッド |
高い炭水化物抗原密度を有するワクチン及び新規サポニンアジュバント
|
WO2014136064A2
(en)
|
2013-03-08 |
2014-09-12 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
US9707153B2
(en)
|
2013-04-24 |
2017-07-18 |
Corning Incorporated |
Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
|
CN104140972B
(zh)
*
|
2013-05-07 |
2018-01-23 |
上海惠盾生物技术有限公司 |
白喉毒素突变体crm197的制备方法
|
CN105705467B
(zh)
|
2013-08-26 |
2019-09-27 |
康宁股份有限公司 |
用于化学强化的玻璃的局部退火的方法
|
CA2923129C
(en)
|
2013-09-08 |
2020-06-09 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
US11708411B2
(en)
|
2013-12-20 |
2023-07-25 |
Wake Forest University Health Sciences |
Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
|
US11160855B2
(en)
|
2014-01-21 |
2021-11-02 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
AU2015208820B2
(en)
|
2014-01-21 |
2020-05-14 |
Pfizer Inc. |
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
|
IL246738B1
(en)
|
2014-01-21 |
2024-04-01 |
Pfizer |
Capsular polysaccharides of Streptococcus pneumoniae and their conjugates
|
PE20161095A1
(es)
|
2014-01-21 |
2016-10-26 |
Pfizer |
Composiciones inmunogenicas que comprenden antigenos de sacaridos capsulares conjugados y uso de los mismos
|
KR102282930B1
(ko)
|
2014-01-31 |
2021-07-27 |
피나 바이오솔루션스, 엘엘씨 |
Crm197 및 관련 단백질의 발현 및 정제
|
ES2930318T3
(es)
|
2014-02-14 |
2022-12-09 |
Pfizer |
Conjugados glucoproteicos inmunogénicos
|
US9815886B2
(en)
|
2014-10-28 |
2017-11-14 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
BR112017010718A2
(pt)
|
2014-11-20 |
2017-12-26 |
Biological E Ltd |
polinucleotídeo otimizado por códon para expressão de alto nível de crm197
|
IL252915B2
(en)
|
2015-01-15 |
2024-04-01 |
Pfizer |
Immunogenic preparations for use in pneumococcal vaccines
|
BR112017017460A2
(pt)
|
2015-02-19 |
2018-04-10 |
Pfizer Inc. |
composições de neisseria meningitidis e métodos das mesmas
|
TWI718144B
(zh)
|
2015-05-04 |
2021-02-11 |
美商輝瑞股份有限公司 |
B型鏈球菌多醣-蛋白質軛合物、製造軛合物之方法、含軛合物之免疫原性組成物、及其用途
|
RS61440B1
(sr)
|
2015-06-23 |
2021-03-31 |
Biological E Ltd |
Multivalentna pneumokokna konjugatna vakcina
|
JP6994453B2
(ja)
|
2015-07-21 |
2022-01-14 |
ファイザー・インク |
コンジュゲート化莢膜糖類抗原を含む免疫原性組成物、それを含むキットおよびこれらの使用
|
WO2017085586A1
(en)
|
2015-11-20 |
2017-05-26 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
EP3426785A4
(en)
|
2016-03-10 |
2019-12-25 |
The Johns Hopkins University |
METHOD FOR PRODUCING AGGREGATE-FREE MONOMER DIPHTHERIETOXINFUSION PROTEINS AND THERAPEUTIC USES
|
US11965009B2
(en)
|
2016-03-10 |
2024-04-23 |
The Johns Hopkins University |
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
|
US11203626B2
(en)
|
2016-03-10 |
2021-12-21 |
The Johns Hopkins University |
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
|
WO2017220753A1
(en)
|
2016-06-22 |
2017-12-28 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pneumococcal polysaccharide-protein conjugate composition
|
EP3269385A1
(en)
|
2016-07-12 |
2018-01-17 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pneumococcal polysaccharide-protein conjugate composition
|
CA3031799A1
(en)
|
2016-08-05 |
2018-02-08 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
KR102467074B1
(ko)
|
2016-08-05 |
2022-11-11 |
사노피 파스퇴르 인코포레이티드 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
UA126385C2
(uk)
|
2016-09-30 |
2022-09-28 |
Байолоджикал І Лімітед |
Композиції полівалентної пневмококової вакцини, що містять кон'югати полісахарид-білок
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
WO2018126229A2
(en)
|
2016-12-30 |
2018-07-05 |
Sutrovax, Inc. |
Polypeptide-antigen conjugates with non-natural amino acids
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
AU2018208844B2
(en)
|
2017-01-20 |
2021-02-25 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
SG10202111092UA
(en)
|
2017-01-31 |
2021-11-29 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
KR102650073B1
(ko)
|
2017-01-31 |
2024-03-20 |
머크 샤프 앤드 돔 엘엘씨 |
스트렙토코커스 뉴모니아 혈청형 19f 유래의 협막 다당류 단백질 접합체의 제조 방법
|
KR101908590B1
(ko)
|
2017-02-01 |
2018-10-16 |
(주)포바이오코리아 |
Crm197의 용해성 단백질 발현 및 정제 방법
|
CA3052621A1
(en)
|
2017-02-03 |
2018-08-09 |
Schadeck, Eva Barbara |
Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
IL270075B2
(en)
|
2017-04-22 |
2024-06-01 |
Biological E Ltd |
An improved method for producing a high level of CRM
|
EP3678654B1
(en)
|
2017-09-07 |
2024-06-26 |
Merck Sharp & Dohme LLC |
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
|
KR102481327B1
(ko)
|
2017-12-06 |
2022-12-23 |
머크 샤프 앤드 돔 엘엘씨 |
스트렙토코쿠스 뉴모니아에 폴리사카라이드-단백질 접합체를 포함하는 조성물 및 그의 사용 방법
|
KR102475419B1
(ko)
*
|
2018-07-16 |
2022-12-07 |
주식회사 유바이오로직스 |
Crm197을 고농도로 발현하는 코리네박테리움 균주
|
US11260119B2
(en)
|
2018-08-24 |
2022-03-01 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
CN109100517A
(zh)
*
|
2018-10-08 |
2018-12-28 |
武汉生命科技股份有限公司 |
一种用于检测白喉抗体的抗原蛋白、试剂盒及制备方法
|
EP3893926A1
(en)
|
2018-12-12 |
2021-10-20 |
Pfizer Inc. |
Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
|
PE20211888A1
(es)
|
2018-12-19 |
2021-09-22 |
Merck Sharp & Dohme |
Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y sus metodos de uso
|
JP7239509B6
(ja)
|
2019-02-22 |
2023-03-28 |
ファイザー・インク |
細菌多糖類を精製するための方法
|
JP2022528158A
(ja)
|
2019-04-10 |
2022-06-08 |
ファイザー・インク |
コンジュゲート化莢膜糖抗原を含む免疫原性組成物、それを含むキットおよびその使用
|
WO2021021729A1
(en)
|
2019-07-31 |
2021-02-04 |
Sanofi Pasteur Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
CN114667343A
(zh)
|
2019-11-01 |
2022-06-24 |
辉瑞大药厂 |
大肠杆菌组合物及其方法
|
CA3171864A1
(en)
|
2020-02-21 |
2021-08-26 |
Pfizer Inc. |
Purification of saccharides
|
IL295632A
(en)
|
2020-02-23 |
2022-10-01 |
Pfizer |
Escherichia coli preparations and their methods
|
EP3900739A1
(en)
|
2020-04-21 |
2021-10-27 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Synthetic streptococcus pneumoniae saccharide conjugates to conserved membrane protein
|
EP3919076A1
(en)
|
2020-06-02 |
2021-12-08 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Synthetic oligosaccharide vaccines against streptococcus pneumoniae with microparticle adjuvant formulations
|
US20230321212A1
(en)
|
2020-08-26 |
2023-10-12 |
Pfizer Inc. |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
TW202227128A
(zh)
|
2020-09-17 |
2022-07-16 |
美商詹森藥物公司 |
多價疫苗組成物及其用途
|
US20230383324A1
(en)
|
2020-10-22 |
2023-11-30 |
Pfizer Inc. |
Methods for purifying bacterial polysaccharides
|
CA3199610A1
(en)
|
2020-10-27 |
2022-05-05 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
EP4240410A1
(en)
|
2020-11-04 |
2023-09-13 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
JP2023549736A
(ja)
|
2020-11-10 |
2023-11-29 |
ファイザー・インク |
コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用
|
US20220202923A1
(en)
|
2020-12-23 |
2022-06-30 |
Pfizer Inc. |
E. coli fimh mutants and uses thereof
|
KR20220102871A
(ko)
|
2021-01-14 |
2022-07-21 |
(주)셀트리온 |
다가 폐렴구균 다당류-단백질 접합체를 포함하는 면역원성 조성물
|
TW202245835A
(zh)
|
2021-02-04 |
2022-12-01 |
美商默沙東有限責任公司 |
用於肺炎球菌結合物疫苗之奈米乳化液佐劑組合物
|
WO2022234416A1
(en)
|
2021-05-03 |
2022-11-10 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
JP2024517780A
(ja)
|
2021-05-03 |
2024-04-23 |
ファイザー・インク |
細菌およびベータコロナウイルス感染症に対するワクチン接種
|
EP4346893A2
(en)
|
2021-05-28 |
2024-04-10 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
WO2022249106A2
(en)
|
2021-05-28 |
2022-12-01 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
AU2023207315A1
(en)
|
2022-01-13 |
2024-06-27 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
WO2023161817A1
(en)
|
2022-02-25 |
2023-08-31 |
Pfizer Inc. |
Methods for incorporating azido groups in bacterial capsular polysaccharides
|
WO2023218322A1
(en)
|
2022-05-11 |
2023-11-16 |
Pfizer Inc. |
Process for producing of vaccine formulations with preservatives
|
WO2024084397A1
(en)
|
2022-10-19 |
2024-04-25 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
WO2024089001A1
(en)
|
2022-10-24 |
2024-05-02 |
Idorsia Pharmaceuticals Ltd |
Vaccine against klebsiella pneumoniae
|
WO2024110827A1
(en)
|
2022-11-21 |
2024-05-30 |
Pfizer Inc. |
Methods for preparing conjugated capsular saccharide antigens and uses thereof
|
WO2024110839A2
(en)
|
2022-11-22 |
2024-05-30 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
WO2024116096A1
(en)
|
2022-12-01 |
2024-06-06 |
Pfizer Inc. |
Pneumococcal conjugate vaccine formulations
|
WO2024121280A1
(en)
|
2022-12-08 |
2024-06-13 |
Idorsia Pharmaceuticals Ltd |
Vaccine against klebsiella pneumoniae
|